Investor Warning: Berger Montague advises investors Regeneon Pharmaceuticals, Inc. (Regn) to inquire about the fraud class action with securities until March 10, 2025.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.